A3P Biomedical
Biocrine
byWiT
Cascade Drives
Dirac Research
Doktor.se
Exeger
GreenGold Group
Kaunis Iron
Klarna
Marshall Group
MEDS Pharmacy
Mentimeter
Nicoya
Virtune
Xshore
Yabie
Sigrid therapeutics Stock
Private company
Bid
SEK
Ask
SEK
Latest trade
SEK
Marknadsvärde
SEK
6 months
SEK
Price is based on the latest closing on the date indicated
Sigrid therapeutics
Buy Sigrid Therapeutics share
- On Eqvor's platform, you can both view Sigrid Therapeutics' stock price and submit a sell or buy request via the buy and sell buttons.
- You can contact us with any questions and concerns regarding Sigrid Therapeutics AB.
Sigrid Therapeutics is affiliated with Euroclear, after execution of the order, the shares are delivered to your custody account at any bank or securities company.
About the share
Sigrid Therapeutics AB
Org. Number
556958-3023
Result after net financial items
-30 607 TSEK
1 269 TSEK
23 154 025 st
-30 607 TSEK
Current liabilities
9 684 TSEK
Long-term liabilities
-
-
10 Largest Owners Sigrid Therapeutics
Name
capital
Name
capital
Ulf Wiinberg
23,54%
M.G.A. HOLDING COMPANY LIMITED BY SHARES
9,24%
AXC Innovation II AB
2,97%
Opis Luma AB
2,95%
ALMI Invest Stockholm AB
2,72%
AVACADO LIMITED LIABILITY COMPANY
2,62%
TBRC Research & Development AB
2,04%
Crosslight Food A AB
1,94%
Sana Alajmovic
1,77%
Ackelsta AB
1,57%
About the pipeline
The President
Claes Mattias Ankarberg
Step 1: Place an "order"
Click on the buy or sell button.
Step 2: Signing the mandate agreement
One of our employees will contact you to confirm the order by signing a mandate agreement. This is a standardized agreement that gives us the right to complete a transaction based on your given instructions. This is signed digitally.
Step 3: Matching the orders
We match your buy or sell order against other customers' orders.
Step 4: The transaction is finalized
A contract is sent to both the buyer and the seller in the transaction with instructions on where the shares are to be delivered, the payment to be made, and other information about the business relationship.
About Sigrid Therapeutics
Sigrid Therapeutics is a Swedish biotech company developing innovative solutions to improve metabolic health and prevent lifestyle diseases such as type 2 diabetes. The company was founded in 2014 by Dr. Sana Alajmovic and Dr. Tore Bengtsson and is headquartered in Stockholm. Their patented technology is based on groundbreaking research in nanotechnology and is focused on improving sugar and fat metabolism in a safe and effective way.
Products and technology
SiPore
The company's core technology, SiPore®, is a nanoporous silica particle developed to reduce the absorption of nutrients in the gastrointestinal tract, leading to improved blood sugar control and weight loss. The product is unique in its mechanical action and is not absorbed by the body, making it safe and free from systemic side effects.
Indications for use and target groups
Sigrid's initial focus is on addressing prediabetes and obesity, two conditions that affect millions of people globally and are major risk factors for the development of type 2 diabetes and cardiovascular disease. The company's solution is particularly relevant at a time when diet- and lifestyle-related diseases represent one of the biggest challenges for healthcare.
Business model and market potential
Sigrid Therapeutics' SiPore® is planned to be launched as a medical device. The company is targeting a rapidly growing global market for diet-related health, with a focus on North America, Europe and Asia. The prediabetes and obesity market is estimated to be worth several billion dollars.
Clinical progress and regulatory approval
Sigrid has successfully completed several clinical studies demonstrating the safety and efficacy of SiPore® in improving blood glucose levels and reducing body weight. The company is now working to obtain regulatory approval in the EU and other key markets, paving the way for commercialization.
Financial developments
2021: turnover decreased to 50 TSEK
2022: turnover increased to 17 TSEK
2023: turnover increased to approximately SEK 1,269 thousand
In recent years, Sigrid Therapeutics has reported negative results for 2021, 2022 and 2023. However, the company has recorded positive growth in its total revenue for these years, with the increase between 2022 and 2023 being particularly strong.
Funding and future
Sigrid Therapeutics has secured funding in several rounds, which has enabled the company's continued development. The capital is being used to expand production capacity, conduct further studies and prepare for market launch.
With an innovative technology, a large addressable market and strong clinical data, Sigrid Therapeutics is well positioned to become a player in the field of metabolic health solutions.
How to buy shares in Sigrid Therapeutics
- Create an account on Eqvor.com
- Click the buy button next to Sigrid Therapeutics in the OTC list.
- Choose how many shares you want to buy and at what price, and to which depository you want the shares delivered.
- Wait for the order to be matched.
- Send your settlement note to your bank/securities company.
- The shares land in your custody - Done!
In addition to Sigrid, we have also helped investors buy and sell shares in other exciting unlisted companies in sectors such as
Health and biotechnology, where there are A3P Biomedical, BioCrine, Doktor.se, MEDS Pharmacy and Mindler. Under financial services there are Klarna, Mynt, Yabie and Billogram.
In technology and innovation: Dirac Research, Exeger, Cascade Drives, Sana Labs, Quartr, Mentimeter and Virtune. In the consumer and lifestyle segment: CDLP, Estrid and Marshall.
Under transport and vehicle technology there are Einride, Voi, XShore, Koenigsegg and Candela. In energy and sustainability: Blykalla and Svea Solar.
In addition: Epidemic Sound (media), Kaunis Iron (industry), GreenGold Group (forestry), and investment companies Röko, byWiT and Nicoya.
We can also help to implement deals in other unlisted companies - even if they are not listed on the platform. Contact us if you are looking for a specific case.
Frequently asked questions and answers about Sigrid therapeutics
Is Sigrid Therapeutics listed on the stock exchange?
No, Sigrid Therapeutics is not listed. If you want to buy shares before listing, you can do so at Eqvor.com
Is Sigrid Therapeutics affiliated with Euroclear?
Yes, Sigrid Therapeutics is connected to Euroclear, which means you can keep the shares in a regular share depository.
At what price is Sigrid Therapeutics trading?
Log in to Eqvor.com to get the latest courses in Sigrid Therapeutics.
When is Sigrid Therapeutics going public?
There is no set date for the IPO at this stage.
Can I store Sigrid Therapeutics on Avanza?
Yes, you can keep the shares in a regular share depository at Avanza.
What is the valuation of Sigrid Therapeutics?
To see the valuation of Sigrid Therapeutics create an account on Eqvor and you will see the current valuation at the top of this page under the heading "Market capitalization" this valuation is calculated based on the last trade in the stock.
When did Sigrid Therapeutics last issue shares?
To see the latest issue in Sigrid Therapeutics log in to Eqvor and look at the graph, where you will see a purple dot in the graph for each issue with the capital raised and the share price at each issue.
